News and Links

Recent News & Press Releases

Recent News: ATAIRGIN TECHNOLOGIES and PEGGY FLEMING Join Forces In The Fight Against Women's Cancers
Press Release: Debra Liebert Named Vice President of Corporate Development
Historical Press Releases

Recent News

A CHAMPIONSHIP TEAM:
ATAIRGIN TECHNOLOGIES and PEGGY FLEMING
hotels in PisaJoin Forces In The Fight Against Women's Cancers

Peggy Fleming

Celebrated figure skating champion and breast cancer survivor, Peggy Fleming, is best known for her style, grace, and courage. Her accomplishments include five U.S. National titles, three World titles, and the Olympic gold medal from the 1968 Olympic Winter Games in Grenoble, France. It was the only gold medal the United States brought home from those games.

Peggy, 52, has starred in five of her own television specials, one of which won two Emmy Awards, and in 1980, she was honored at the Sports Illustrated 20th Century Awards as one of seven "Athletes Who Changed the Game", a category that included Billie Jean King, Arnold Palmer, and Jackie Robinson.

Throughout Peggy's career, she has been a spokesperson for a variety of women's health issues, including breast cancer awareness, osteoporosis, and fitness for women after 40. For the last 20 years, she also has provided commentary for ABC Sports' figure skating telecasts.

In February of 1998, Peggy was diagnosed with breast cancer and underwent a lumpectomy on the 30th anniversary of winning her Olympic gold medal. After completing successful radiation treatment, she began work on her autobiography, The Long Program, Skating Towards Life's Victories, which was a best seller in cities across the US.

For the last 30 years she has been married to dermatologist, Greg Jenkins. They live in the San Francisco Bay Area and have two sons, Andy and Todd. In 1999, Peggy also became a proud grandmother to her first grandson.

back to recent news

Press Release

August 2 , 2001

Contact: Rob Goshert
(800) 833 1193
Vice President, Business Operations

Rob Whetstone or Rosemary Moothart
PondelWilkinson MS&L
(310) 207 9300

FOR IMMEDIATE RELEASE

DEBRA LIEBERT NAMED VICE PRESIDENT OF CORPORATE DEVELOPMENT FOR ATAIRGIN TECHNOLOGIES

Irvine, California - August 2, 2001 - Atairgin Technologies, Inc., dedicated to improving the quality of care in women's health, today announced it has appointed Debra K. Liebert as vice president of corporate development. Liebert will be responsible for directing business development activities, including establishing corporate partnerships and leading the development of strategic planning. She will report to Patrick D. Walsh, chief executive officer of Atairgin.

"With extensive experience in corporate development as well as in drug discovery and development, Debra brings considerable business and industry expertise to our team as our research and clinical trials move us closer to commercialization," said Walsh. "At this exciting stage of our development, we are pleased to have someone of Debra's caliber on board."

Liebert, 45, comes to Atairgin with more than 19 years of experience in the biotechnology and pharmaceutical industries, most recently as vice president of corporate development at Lion bioscience Inc., (formerly Trega Biosciences, Inc.) where she was instrumental in the successful merger and integration of the two companies. As senior director, corporate development, Liebert led corporate transactions involving major partnerships, divestitures and acquisitions. Prior to that, she held the position of senior director, medical and regulatory affairs, and managed the clinical development of new products.

Before Lion bioscience, Liebert was director, clinical research, at Gensia, Inc., where she oversaw the design and implementation of investigational and marketed clinical research. She also held positions at the Institute for Biological Research & Development and Merck & Co., Inc.

Liebert earned a bachelor of science degree in chemistry at Clarion University in Clarion, Pennsylvania. She earned a master of science in pharmacology/toxicology at Duquesne University in Pittsburgh, Pennsylvania, and a master of business administration degree at the Anderson School at the University of California, Los Angeles.

About Atairgin Technologies, Inc.
Atairgin Technologies, Inc., founded in 1996, is a healthcare technology company dedicated to improving the quality of care in women's health. The company's platform technology is based on bioactive lipids, or extra cellular regulating agents, that enable multiple applications in cancer, pregnancy management and reproductive health.

back to recent news

Press Releases: History

(Click on the colored date bars to view individual press releases.) Glasgow alberghi a tariffe promozionali
Atairgin Technologies announces Debra Liebert as Vice President of Corporate Development.
Atairgin announced the Promotion of Rob Goshert to Vice President of Business Operations and Kiu Leung, Ph.D., to Vice President of Diagnostics.
Atairgin Completed Patient Accrual for its Nationwide Clinical Trial Designed to Evaluate a Promising Diagnostic Marker for ovarian cancer.

Skating legend Peggy Fleming and Atairgin Technologies join forces in the fight against women's cancers.
back to recent news

Thursday, Feb 8, 2001

Atairgin Technologies Announces Ovarian Cancer Research Involving Its Novel Lipid Technology.

Atairgin Technologies Completes Series D Financing.

Atairgin Technologies Announces Executive Appointments.
back to recent news

Atairgin Technologies Moves to UC Irvine Research Park.

Atairgin Technologies names financial industry veteran Susan Foley to Board of Directors.

Atairgin Technologies Participates in Donation Program with Gynecologic Cancer Foundation.

Atairgin Technologies Creates New Clinical Advisory Board.
back to recent news

Monday, February 7, 2000

hotels in ViennaAtairgin Technologies To cheap hotels in HelsingborgBegin Patient Enrollment With LPA Ovarian Cancer Blood Test.

Atairgin Technologies Names Nationally Known Ovarian Cancer Expert to Clinical Advisory Board.

Atairgin and The Cleveland Clinic Foundation Announce Technology Patent for Application in Ovarian Cancer.

Thursday, October 14, 1999

Atairgin Participates in NCI-Sponsored Ovarian Cancer Research Network.
back to recent news

Atairgin Technologies Presents at Emerging Medical Technologies Conference.

Atairgin Technologies Blood Test for Ovarian Cancer Demonstrates Early Stage Tumor Detection.

Atairgin Technologies and Washington State University Partner to Develop New Product Applications.

Atairgin and Northwestern University Join Forces to Develop Ovarian Cancer Diagnostic.

Atairgin Expands Oncology Research Program with MD Anderson Cancer Center.